Related Experiment Video
Updated: Sep 21, 2025
07:41
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
Published on: July 20, 2022
2.0K
COVID-19 Vaccination-Induced Cardiomyopathy Requiring Permanent Left Ventricular Assist Device.
Muhammad Z Khan1, Scott Janus2, Sona Franklin1
1Internal Medicine, St. Mary Medical Center, Langhorne, USA.
Cureus
|June 2, 2022
Summary
Myocarditis is a rare but serious side effect of mRNA COVID-19 vaccines, especially in young males. This case highlights potential irreversible cardiomyopathy following vaccination, even in healthy individuals.
Area of Science:
- Cardiology
- Vaccinology
- Public Health
Background:
- mRNA vaccines for COVID-19 are widely used.
- Myocarditis is a known rare adverse event associated with these vaccines.
- Young males are identified as a higher-risk demographic.
Observation:
- A case report of a young, obese male presented with abdominal pain during the COVID-19 pandemic.
- The patient was diagnosed with severe myocarditis/cardiomyopathy.
- The condition was likely linked to mRNA-based COVID-19 vaccination.
Findings:
- The patient required left ventricular assist device (LVAD) implantation due to severe cardiac dysfunction.
- This case underscores the potential for mRNA COVID-19 vaccines to cause severe myocarditis/cardiomyopathy.
- A high index of suspicion is warranted for vaccine-induced cardiac complications, particularly in those with prior COVID-19 infection.
Implications:
- Clinicians should consider myocarditis as a potential complication of mRNA COVID-19 vaccination.
- Early recognition and management are crucial for patients presenting with cardiac symptoms post-vaccination.
- Further research may be needed to understand the long-term implications and risk factors for vaccine-associated myocarditis.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
44
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
44
01:30Cardiomyopathy II: Dilated Cardiomyopathy
36
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
36
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
71
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
71
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
48
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
48
01:29Cardiomyopathy VI: Nursing Management
53
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
53
01:14Myocarditis III: Medical Management
24
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
24